Nasdaq

NanoViricides’ President Dr. Anil Diwan was Interviewed by Proactive Investors About the Company’s Antiviral Drug Development Against SARS-CoV-2 to Treat COVID-19

The Company has completed the synthesis of a number of nanoviricide drug candidates for testing in just a few weeks after identification of virus-binding ligands. Additionally, the polymer backbone ...
Nasdaq

Proactive Interviews NexTech AR Solutions Chief Executive Evan Gappelberg Who Discusses Just Why His New SaaS Model Is a 'Big Deal'

TORONTO, ON / ACCESSWIRE / December 2, 2021 / Proactive announces the release of a video interview with NexTech AR Solutions Corp. (OTCQB:NEXCF) (NEO:NTAR) (CSE:NTAR) (FSE:N29) chief executive Evan ...
Managingip.com

Interview: Danny Friedmann, Trademark Proactive

Danny Friedmann has an idea to stop the rampant misuse of brands by users of social media. It involves brand owners giving up some of their rights to trade marks and logos, such as the ability to ...
Business Insider

Proactive Teams Up With OTC Markets Group to Film Executive Interviews From OTC Markets’ NYC Headquarters

NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Proactive, the digital financial news organization, is teaming up with OTC Markets Group to film executive interviews from the OTC Markets’ New York ...
Business Insider

NanoViricides’ President Dr. Anil Diwan was Interviewed by Proactive Investors About the Company’s Antiviral Drug Development Against SARS-CoV-2 to Treat COVID-19

SHELTON, CT / ACCESSWIRE / April 13, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...